guest ::
| Home > Publications database > Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. > print |
| Home > Publications database > Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. > print |
| 001 | 182103 | ||
| 005 | 20241228120953.0 | ||
| 024 | 7 | _ | |a 10.1007/s00432-022-04407-1 |2 doi |
| 024 | 7 | _ | |a pmid:36241862 |2 pmid |
| 024 | 7 | _ | |a 0084-5353 |2 ISSN |
| 024 | 7 | _ | |a 0171-5216 |2 ISSN |
| 024 | 7 | _ | |a 0943-9382 |2 ISSN |
| 024 | 7 | _ | |a 1432-1335 |2 ISSN |
| 024 | 7 | _ | |a altmetric:137291705 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-02421 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Arndt, Volker |0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. |
| 260 | _ | _ | |a Berlin |c 2023 |b Springer |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2022-10-14 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2023-02-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2023-02-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1676991683_21827 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:C071#EA:C070#LA:E220# / 2023 Feb;149(2):913-919 |
| 520 | _ | _ | |a An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future. |
| 536 | _ | _ | |a 315 - Bildgebung und Radioonkologie (POF4-315) |0 G:(DE-HGF)POF4-315 |c POF4-315 |f POF IV |x 0 |
| 542 | _ | _ | |i 2022-10-14 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 542 | _ | _ | |i 2022-10-14 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Aftercare |2 Other |
| 650 | _ | 7 | |a Comprehensive cancer centers |2 Other |
| 650 | _ | 7 | |a Early diagnosis of cancer |2 Other |
| 650 | _ | 7 | |a SARS-CoV-2 infection |2 Other |
| 650 | _ | 7 | |a Treatment delays |2 Other |
| 700 | 1 | _ | |a Doege, Daniela |0 P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b |b 1 |e First author |u dkfz |
| 700 | 1 | _ | |a Fröhling, Stefan |0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d |b 2 |u dkfz |
| 700 | 1 | _ | |a Albers, Peter |b 3 |
| 700 | 1 | _ | |a Algül, Hana |b 4 |
| 700 | 1 | _ | |a Bargou, Ralf |0 0000-0002-1221-7421 |b 5 |
| 700 | 1 | _ | |a Bokemeyer, Carsten |0 0000-0001-6071-7810 |b 6 |
| 700 | 1 | _ | |a Bornhäuser, Martin |b 7 |
| 700 | 1 | _ | |a Brandts, Christian H |0 0000-0003-1732-2535 |b 8 |
| 700 | 1 | _ | |a Brossart, Peter |b 9 |
| 700 | 1 | _ | |a Brucker, Sara Yvonne |0 0000-0001-5162-1542 |b 10 |
| 700 | 1 | _ | |a Brümmendorf, Tim H |0 0000-0002-9677-3723 |b 11 |
| 700 | 1 | _ | |a Döhner, Hartmut |0 0000-0003-2116-5536 |b 12 |
| 700 | 1 | _ | |a Gattermann, Norbert |0 0000-0002-9792-2495 |b 13 |
| 700 | 1 | _ | |a Hallek, Michael |0 0000-0002-7425-4455 |b 14 |
| 700 | 1 | _ | |a Heinemann, Volker |0 0000-0002-1349-3321 |b 15 |
| 700 | 1 | _ | |a Keilholz, Ulrich |b 16 |
| 700 | 1 | _ | |a Kindler, Thomas |0 0000-0002-0383-0507 |b 17 |
| 700 | 1 | _ | |a von Levetzow, Cornelia |b 18 |
| 700 | 1 | _ | |a Lordick, Florian |0 0000-0001-8591-9339 |b 19 |
| 700 | 1 | _ | |a Neumann, Ulf Peter |0 0000-0002-3831-8917 |b 20 |
| 700 | 1 | _ | |a Peters, Christoph |b 21 |
| 700 | 1 | _ | |a Schadendorf, Dirk |0 0000-0003-3524-7858 |b 22 |
| 700 | 1 | _ | |a Stilgenbauer, Stephan |0 0000-0002-6830-9296 |b 23 |
| 700 | 1 | _ | |a Zander, Thomas |0 0000-0002-4266-6818 |b 24 |
| 700 | 1 | _ | |a Zips, Daniel |0 0000-0001-5779-9675 |b 25 |
| 700 | 1 | _ | |a Braun, Delia |0 P:(DE-He78)5df998d953f664b5230be9553e48e293 |b 26 |u dkfz |
| 700 | 1 | _ | |a Seufferlein, Thomas |0 0000-0003-3259-0810 |b 27 |
| 700 | 1 | _ | |a Nettekoven, Gerd |b 28 |
| 700 | 1 | _ | |a Baumann, Michael |0 P:(DE-He78)933f7d725ac87378f459623783585a1f |b 29 |e Last author |u dkfz |
| 773 | 1 | 8 | |a 10.1007/s00432-022-04407-1 |b Springer Science and Business Media LLC |d 2022-10-14 |n 2 |p 913-919 |3 journal-article |2 Crossref |t Journal of Cancer Research and Clinical Oncology |v 149 |y 2022 |x 0171-5216 |
| 773 | _ | _ | |a 10.1007/s00432-022-04407-1 |0 PERI:(DE-600)1459285-X |n 2 |p 913-919 |t Journal of cancer research and clinical oncology |v 149 |y 2022 |x 0171-5216 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:182103 |p VDB |p OpenAPC |p openCost |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 26 |6 P:(DE-He78)5df998d953f664b5230be9553e48e293 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 29 |6 P:(DE-He78)933f7d725ac87378f459623783585a1f |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-315 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Bildgebung und Radioonkologie |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J CANCER RES CLIN : 2022 |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-21 |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 920 | 2 | _ | |0 I:(DE-He78)E220-20160331 |k E220 |l E220 Radioonkologie Radiobiologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)B340-20160331 |k B340 |l Translationale Medizinische Onkologie |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)E220-20160331 |k E220 |l E220 Radioonkologie Radiobiologie |x 3 |
| 920 | 0 | _ | |0 I:(DE-He78)C071-20160331 |k C071 |l C071 Cancer Survivorship |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C071-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C070-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B340-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E220-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a APC |
| 999 | C | 5 | |a 10.1016/j.esmoop.2020.100038 |9 -- missing cx lookup -- |1 M Aapro |p 100038 - |2 Crossref |u Aapro M, Lyman GH, Bokemeyer C, Rapoport BL, Mathieson N, Koptelova N, Cornes P, Anderson R, Gascon P, Kuderer NM (2021) Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open 6:100038. https://doi.org/10.1016/j.esmoop.2020.100038 |t ESMO Open |v 6 |y 2021 |
| 999 | C | 5 | |a 10.1186/s13045-020-00984-1 |9 -- missing cx lookup -- |1 AG Dinmohamed |p 147 - |2 Crossref |u Dinmohamed AG, Cellamare M, Visser O, de Munck L, Elferink MAG, Westenend PJ, Wesseling J, Broeders MJM, Kuipers EJ, Merkx MAW, Nagtegaal ID, Siesling S (2020a) The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J Hematol Oncol 13:147. https://doi.org/10.1186/s13045-020-00984-1 |t J Hematol Oncol |v 13 |y 2020 |
| 999 | C | 5 | |a 10.1016/S1470-2045(20)30265-5 |9 -- missing cx lookup -- |1 AG Dinmohamed |p 750 - |2 Crossref |u Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, Merkx MAW, Lemmens V, Nagtegaal ID, Siesling S (2020b) Fewer cancer diagnoses during the COVID-19 epidemic in The Netherlands. Lancet Oncol 21:750–751. https://doi.org/10.1016/S1470-2045(20)30265-5 |t Lancet Oncol |v 21 |y 2020 |
| 999 | C | 5 | |a 10.1016/j.lanepe.2021.100188 |1 F Erdmann |9 -- missing cx lookup -- |2 Crossref |u Erdmann F, Wellbrock M, Trubenbach C, Spix C, Schrappe M, Schuz J, Grabow D, Eichinger M (2021) Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: evidence from the German Childhood Cancer Registry and a qualitative survey. Lancet Reg Health Eur 9:100188. https://doi.org/10.1016/j.lanepe.2021.100188 |t Lancet Reg Health Eur |v 9 |y 2021 |
| 999 | C | 5 | |a 10.1016/j.breast.2020.05.006 |9 -- missing cx lookup -- |1 ML Gasparri |p 110 - |2 Crossref |u Gasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P (2020) Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 52:110–115. https://doi.org/10.1016/j.breast.2020.05.006 |t Breast |v 52 |y 2020 |
| 999 | C | 5 | |2 Crossref |u Günster C, Drogan D, Hentschker C, Klauber J, Malzahn J, Schillinger G, Mostert C (2020) WIdO-Report: Entwicklung der Krankenhausfallzahlen während des Coronavirus-Lockdowns. Nach ICD-Diagnosekapiteln und ausgewählten Behandlungsanlässen [WIdO Report: Development of Hospital Case Numbers during the Coronavirus Lockdown. By ICD Diagnosis Chapters and Selected Treatment Causes]. Wissenschaftliches Institut der AOK (WldO) im AOK-Bundesverband GbR, Berlin |
| 999 | C | 5 | |a 10.1001/jamanetworkopen.2020.17267 |9 -- missing cx lookup -- |1 HW Kaufman |p e2017267 - |2 Crossref |u Kaufman HW, Chen Z, Niles J, Fesko Y (2020) Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open 3:e2017267. https://doi.org/10.1001/jamanetworkopen.2020.17267 |t JAMA Netw Open |v 3 |y 2020 |
| 999 | C | 5 | |a 10.1200/CCI.21.00074 |9 -- missing cx lookup -- |1 HW Kaufman |p 1028 - |2 Crossref |u Kaufman HW, Chen Z, Niles JK, Radcliff J, Fesko Y (2021) Patterns of prostate-specific antigen testing and prostate biopsies during the COVID-19 pandemic. JCO Clin Cancer Inform 5:1028–1033. https://doi.org/10.1200/CCI.21.00074 |t JCO Clin Cancer Inform |v 5 |y 2021 |
| 999 | C | 5 | |a 10.1111/jdv.18217 |9 -- missing cx lookup -- |1 J Kleemann |p 1766 - |2 Crossref |u Kleemann J, Meissner M, Ozistanbullu D, Balaban U, Old O, Kippenberger S, Kloka J, Kaufmann R, Zacharowski K, Friedrichson B (2022) Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany—a nationwide analysis. J Eur Acad Dermatol Venereol 36:1766–1773. https://doi.org/10.1111/jdv.18217 |t J Eur Acad Dermatol Venereol |v 36 |y 2022 |
| 999 | C | 5 | |a 10.1007/s15015-018-3998-7 |9 -- missing cx lookup -- |1 F Klein |p 81 - |2 Crossref |u Klein F (2018) Netzwerk Onkologische Spitzenzentren—Vernetzung für eine bessere Patientenversorgung [Network of oncology centers of excellence—networking for better patient care]. Im Focus Onkol 21:81–83 |t Im Focus Onkol |v 21 |y 2018 |
| 999 | C | 5 | |a 10.1080/0284186X.2020.1837392 |9 -- missing cx lookup -- |1 M Maluchnik |p 28 - |2 Crossref |u Maluchnik M, Podwojcic K, Wieckowska B (2021) Decreasing access to cancer diagnosis and treatment during the COVID-19 pandemic in Poland. Acta Oncol 60:28–31. https://doi.org/10.1080/0284186X.2020.1837392 |t Acta Oncol |v 60 |y 2021 |
| 999 | C | 5 | |a 10.1016/s1470-2045(20)30388-0 |9 -- missing cx lookup -- |1 C Maringe |p 1023 - |2 Crossref |u Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–1034. https://doi.org/10.1016/s1470-2045(20)30388-0 |t Lancet Oncol |v 21 |y 2020 |
| 999 | C | 5 | |a 10.1053/j.seminoncol.2020.12.002 |9 -- missing cx lookup -- |1 NP Marques |p 156 - |2 Crossref |u Marques NP, Silveira DMM, Marques NCT, Martelli DRB, Oliveira EA, Martelli-Junior H (2021) Cancer diagnosis in Brazil in the COVID-19 era. Semin Oncol 48:156–159. https://doi.org/10.1053/j.seminoncol.2020.12.002 |t Semin Oncol |v 48 |y 2021 |
| 999 | C | 5 | |a 10.4274/ejbh.galenos.2021.2021-1-4 |9 -- missing cx lookup -- |1 C Mathelin |p 188 - |2 Crossref |u Mathelin C, Ame S, Anyanwu S, Avisar E, Boubnider WM, Breitling K, Anie HA, Conceicao JC, Dupont V, Elder E, Elfgen C, Elonge T, Iglesias E, Imoto S, Ioannidou-Mouzaka L, Kappos EA, Kaufmann M, Knauer M, Luzuy F, Margaritoni M, Mbodj M, Mundinger A, Orda R, Ostapenko V, Ozbas S, Ozmen V, Pagani O, Pienkowski T, Schneebaum S, Shmalts E, Selim A, Pavel Z, Lodi M, Maghales-Costa M (2021) Breast cancer management during the COVID-19 pandemic: the senologic international society survey. Eur J Breast Health 17:188–196. https://doi.org/10.4274/ejbh.galenos.2021.2021-1-4 |t Eur J Breast Health |v 17 |y 2021 |
| 999 | C | 5 | |a 10.1038/s43018-020-0074-y |9 -- missing cx lookup -- |1 M Richards |p 565 - |2 Crossref |u Richards M, Anderson M, Carter P, Ebert BL, Mossialos E (2020) The impact of the COVID-19 pandemic on cancer care. Nat Cancer 1:565–567. https://doi.org/10.1038/s43018-020-0074-y |t Nat Cancer |v 1 |y 2020 |
| 999 | C | 5 | |2 Crossref |u Robert Koch-Institute (2022a) COVID-19-Hospitalisierungen in Deutschland [COVID-19 hospitalizations in Germany]. https://github.com/robert-koch-institut/COVID-19-Hospitalisierungen_in_Deutschland. Accessed 22 Sept 2022a |
| 999 | C | 5 | |2 Crossref |u Robert Koch-Institute (2022b) Gesamtübersicht der pro Tag ans RKI übermittelten Fälle und Todesfälle [General survey of cases and deaths transmitted to the RKI per day]. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Daten/Fallzahlen_Gesamtuebersicht.xlsx. Accessed 23 June 2022b |
| 999 | C | 5 | |2 Crossref |u Robert Koch-Institute, DIVI e.V. (2022) DIVI-Intensivregister [DIVI Intensive Care Registry] https://www.intensivregister.de/#/aktuelle-lage/downloads. Accessed 23 June 2022 |
| 999 | C | 5 | |a 10.1007/978-3-662-64685-4_6 |9 -- missing cx lookup -- |2 Crossref |u Rückher J, Mangiapane S, Seufferlein T, Pflüger M, Wesselmann S (2022) Auswirkungen der Covid-19-Pandemie auf die onkologische Versorgung [Impact of the covid 19 pandemic on oncology care]. In: Klauber J, Wasem J, Beivers A, Mostert C (eds) Krankenhaus-Report 2022 [Hospital Report 2022]. Springer, Berlin |
| 999 | C | 5 | |a 10.1080/0284186X.2020.1858235 |9 -- missing cx lookup -- |1 CW Skovlund |p 20 - |2 Crossref |u Skovlund CW, Friis S, Dehlendorff C, Nilbert MC, Morch LS (2021) Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta Oncol 60:20–23. https://doi.org/10.1080/0284186X.2020.1858235 |t Acta Oncol |v 60 |y 2021 |
| 999 | C | 5 | |a 10.3238/arztebl.m2021.0329 |9 -- missing cx lookup -- |1 S Voigtlander |p 660 - |2 Crossref |u Voigtlander S, Hakimhashemi A, Inwald EC, Ortmann O, Gerken M, Klug SJ, Klinkhammer-Schalke M, Meyer M, Muller-Nordhorn J (2021) The impact of the COVID-19 pandemic on cancer incidence and treatment by cancer stage in Bavaria, Germany. Dtsch Arztebl Int 118:660–661. https://doi.org/10.3238/arztebl.m2021.0329 |t Dtsch Arztebl Int |v 118 |y 2021 |
| 999 | C | 5 | |a 10.1159/000508272 |9 -- missing cx lookup -- |1 KC Weisel |p 307 - |2 Crossref |u Weisel KC, Morgner-Miehlke A, Petersen C, Fiedler W, Block A, Schafhausen P, Knobloch JK, Bokemeyer C (2020) Implications of SARS-CoV-2 infection and COVID-19 crisis on clinical cancer care: report of the university cancer center Hamburg. Oncol Res Treat 43:307–313. https://doi.org/10.1159/000508272 |t Oncol Res Treat |v 43 |y 2020 |
| 999 | C | 5 | |2 Crossref |u World Health Organization (2020) COVID-19 significantly impacts health services for noncommunicable diseases. https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases. Accessed 17 June 2022 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|